- Forums
- ASX - By Stock
- PYC
- Ann: Extension of RP11 Single Dose Study Into Multiple Dose Study
Ann: Extension of RP11 Single Dose Study Into Multiple Dose Study, page-2
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $501.6M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 10.5¢ | $300.7K | 2.752M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 896788 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 227374 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 896788 | 0.105 |
24 | 1888322 | 0.100 |
1 | 5100 | 0.098 |
3 | 79605 | 0.095 |
2 | 187912 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 227374 | 11 |
0.115 | 877319 | 10 |
0.120 | 175000 | 1 |
0.125 | 709274 | 8 |
0.130 | 1974341 | 10 |
Last trade - 13.55pm 23/07/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online